Steven H.  Collis net worth and biography

Steven Collis Biography and Net Worth

Steven H. Collis is Chairman, President and CEO of AmerisourceBergen Corporation, a global healthcare solutions leader, currently ranked No.10 on the Fortune 500. He was elected president and CEO in 2011 and chairman in 2016.

Under Mr. Collis’ leadership, AmerisourceBergen has experienced tremendous financial growth. The company’s annual revenue has jumped more than 80% during Mr. Collis’ tenure as CEO and its number of employees has risen to 21,000, with offices in more than 50 countries worldwide. 

Through strategic investments and acquisitions, the company has expanded its breadth of services and solutions resulting in unprecedented customer partnerships, global reach and deep expertise that is shaping healthcare delivery. 

Specifically, AmerisourceBergen’s agreement with Walgreens Boots Alliance in 2013 marked an industry first—with a national pharmacy chain turning over all its pharmaceutical distribution to a wholesaler and collaborating on a global basis for generic product sourcing. The company’s 2015 acquisition of MWI Veterinary Supply further reflect AmerisourceBergen’s ability to deliver value in diverse aspects of patient care and growing markets. As a result, the Wall Street Journal named Mr. Collis as the best performing chief executive in the Philadelphia region for 2015, and Barron’s ranked AmerisourceBergen two years in a row as No. 1 on their list of the 500 top performing companies.

What is Steven H. Collis' net worth?

The estimated net worth of Steven H. Collis is at least $0.00 as of September 12th, 2023. Mr. Collis owns 257,967 shares of AmerisourceBergen stock worth more than $0 as of October 1st. This net worth approximation does not reflect any other assets that Mr. Collis may own. Additionally, Mr. Collis receives a salary of $5,490,000.00 as CEO at AmerisourceBergen. Learn More about Steven H. Collis' net worth.

How old is Steven H. Collis?

Mr. Collis is currently 62 years old. There are 8 older executives and no younger executives at AmerisourceBergen. Learn More on Steven H. Collis' age.

What is Steven H. Collis' salary?

As the CEO of AmerisourceBergen Co., Mr. Collis earns $5,490,000.00 per year. Learn More on Steven H. Collis' salary.

How do I contact Steven H. Collis?

The corporate mailing address for Mr. Collis and other AmerisourceBergen executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. AmerisourceBergen can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Steven H. Collis' contact information.

Has Steven H. Collis been buying or selling shares of AmerisourceBergen?

Steven H. Collis has not been actively trading shares of AmerisourceBergen in the last ninety days. Most recently, Steven H. Collis sold 10,499 shares of the business's stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $186.19, for a transaction totalling $1,954,808.81. Following the completion of the sale, the chief executive officer now directly owns 257,967 shares of the company's stock, valued at $48,030,875.73. Learn More on Steven H. Collis' trading history.

Who are AmerisourceBergen's active insiders?

AmerisourceBergen's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Jane Henney, MD (Director), Lazarus Krikorian (CAO), Robert Mauch (EVP), and Henry McGee, III (Director). Learn More on AmerisourceBergen's active insiders.

Are insiders buying or selling shares of AmerisourceBergen?

During the last year, insiders at the sold shares 21 times. They sold a total of 21,278,817 shares worth more than $3,412,816,690.84. The most recent insider tranaction occured on August, 8th when CEO Steven H Collis sold 10,499 shares worth more than $1,954,808.81. Insiders at AmerisourceBergen own 20.1% of the company. Learn More about insider trades at AmerisourceBergen.

Information on this page was last updated on 8/8/2023.

Steven H. Collis Insider Trading History at AmerisourceBergen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/8/2023Sell10,499$186.19$1,954,808.81257,967View SEC Filing Icon  
7/11/2023Sell10,499$192.87$2,024,942.13257,967View SEC Filing Icon  
6/13/2023Sell10,499$178.44$1,873,441.56257,967View SEC Filing Icon  
5/9/2023Sell10,499$169.52$1,779,790.48257,967View SEC Filing Icon  
4/11/2023Sell10,499$167.34$1,756,902.66257,967View SEC Filing Icon  
3/14/2023Sell10,499$150.00$1,574,850.00257,967View SEC Filing Icon  
1/17/2023Sell10,499$164.28$1,724,775.72257,967View SEC Filing Icon  
12/13/2022Sell45,920$165.62$7,605,270.40257,967View SEC Filing Icon  
10/11/2022Sell11,480$141.72$1,626,945.60205,178View SEC Filing Icon  
9/13/2022Sell11,480$142.40$1,634,752.00205,178View SEC Filing Icon  
8/9/2022Sell11,480$144.25$1,655,990.00205,178View SEC Filing Icon  
7/12/2022Sell11,480$142.35$1,634,178.00205,178View SEC Filing Icon  
6/14/2022Sell11,480$141.22$1,621,205.60205,178View SEC Filing Icon  
4/12/2022Sell11,480$162.11$1,861,022.80205,178View SEC Filing Icon  
3/8/2022Sell11,480$144.97$1,664,255.60View SEC Filing Icon  
2/8/2022Sell24,263$141.22$3,426,420.86View SEC Filing Icon  
1/11/2022Sell24,264$136.07$3,301,602.48View SEC Filing Icon  
12/14/2021Sell24,264$123.95$3,007,522.80View SEC Filing Icon  
11/24/2021Sell17,168$123.66$2,122,994.88View SEC Filing Icon  
11/16/2021Sell11,664$124.66$1,454,034.24View SEC Filing Icon  
11/9/2021Sell24,264$125.33$3,041,007.12View SEC Filing Icon  
10/12/2021Sell24,265$119.79$2,906,704.35View SEC Filing Icon  
9/20/2021Sell24,265$121.90$2,957,903.50View SEC Filing Icon  
8/17/2021Sell12,784$120.53$1,540,855.52View SEC Filing Icon  
7/20/2021Sell12,784$117.66$1,504,165.44199,609View SEC Filing Icon  
7/13/2021Sell20,912$114.90$2,402,788.80View SEC Filing Icon  
6/15/2021Sell12,784$118.82$1,518,994.88201,855View SEC Filing Icon  
6/8/2021Sell20,913$117.65$2,460,414.45209,984View SEC Filing Icon  
5/18/2021Sell12,784$116.35$1,487,418.40204,101View SEC Filing Icon  
4/20/2021Sell12,784$120.07$1,534,974.88206,347View SEC Filing Icon  
4/13/2021Sell20,914$116.96$2,446,101.44214,477View SEC Filing Icon  
3/16/2021Sell33,697$112.71$3,797,988.87216,724View SEC Filing Icon  
7/6/2020Sell19,904$100.59$2,002,143.36162,026View SEC Filing Icon  
4/6/2020Sell19,905$84.75$1,686,948.75162,027View SEC Filing Icon  
2/10/2020Sell19,905$93.20$1,855,146.00162,027View SEC Filing Icon  
1/6/2020Sell19,905$84.42$1,680,380.10162,027View SEC Filing Icon  
11/4/2019Sell19,905$86.08$1,713,422.40154,484View SEC Filing Icon  
10/7/2019Sell19,905$82.12$1,634,598.60154,484View SEC Filing Icon  
9/9/2019Sell19,905$86.89$1,729,545.45154,484View SEC Filing Icon  
8/5/2019Sell19,905$89.58$1,783,089.90154,484View SEC Filing Icon  
6/19/2019Sell107,826$86.18$9,292,444.68242,405View SEC Filing Icon  
3/1/2019Sell21,344$83.62$1,784,785.28155,923View SEC Filing Icon  
2/1/2019Sell21,350$80.72$1,723,372.00155,929View SEC Filing Icon  
1/2/2019Sell21,350$73.96$1,579,046.00155,929View SEC Filing Icon  
12/3/2018Sell21,350$88.92$1,898,442.00View SEC Filing Icon  
11/1/2018Sell21,350$90.92$1,941,142.00View SEC Filing Icon  
10/1/2018Sell21,350$93.09$1,987,471.50View SEC Filing Icon  
9/4/2018Sell21,350$88.33$1,885,845.50287,925View SEC Filing Icon  
8/1/2018Sell21,350$81.25$1,734,687.50287,925View SEC Filing Icon  
7/2/2018Sell21,350$84.63$1,806,850.50287,925View SEC Filing Icon  
6/1/2018Sell21,350$83.08$1,773,758.00287,925View SEC Filing Icon  
5/1/2018Sell21,350$88.49$1,889,261.50View SEC Filing Icon  
4/2/2018Sell21,350$84.03$1,794,040.50View SEC Filing Icon  
3/1/2018Sell21,350$94.25$2,012,237.50View SEC Filing Icon  
2/1/2018Sell21,350$98.58$2,104,683.00287,925View SEC Filing Icon  
1/2/2018Sell21,350$93.54$1,997,079.00View SEC Filing Icon  
12/1/2017Sell21,350$82.53$1,762,015.50287,925View SEC Filing Icon  
11/1/2017Sell21,350$76.94$1,642,669.00260,226View SEC Filing Icon  
9/1/2017Sell15,000$79.92$1,198,800.00253,876View SEC Filing Icon  
7/3/2017Sell15,000$94.76$1,421,400.00253,876View SEC Filing Icon  
6/1/2017Sell15,000$91.73$1,375,950.00253,876View SEC Filing Icon  
5/1/2017Sell15,000$81.98$1,229,700.00253,876View SEC Filing Icon  
4/3/2017Sell15,000$88.35$1,325,250.00253,876View SEC Filing Icon  
2/1/2017Sell15,000$87.15$1,307,250.00253,876View SEC Filing Icon  
12/1/2016Sell15,000$77.94$1,169,100.00238,876View SEC Filing Icon  
11/1/2016Sell15,000$69.85$1,047,750.00231,252View SEC Filing Icon  
10/17/2016Sell15,000$79.59$1,193,850.00231,252View SEC Filing Icon  
12/21/2015Sell27,148$102.23$2,775,340.04252,204View SEC Filing Icon  
12/7/2015Sell9,170$100.06$917,550.20243,734View SEC Filing Icon  
12/4/2015Sell17,978$100.17$1,800,856.26252,204View SEC Filing Icon  
11/18/2015Sell25,948$100.16$2,598,951.68252,204View SEC Filing Icon  
10/27/2015Sell1,200$100.97$121,164.00217,696View SEC Filing Icon  
9/21/2015Sell27,148$105.72$2,870,086.56217,696View SEC Filing Icon  
8/20/2015Sell27,148$104.27$2,830,721.96217,696View SEC Filing Icon  
7/20/2015Sell27,148$114.42$3,106,274.16View SEC Filing Icon  
6/22/2015Sell27,148$112.37$3,050,620.76View SEC Filing Icon  
2/4/2015Sell145,622$96.01$13,981,168.22View SEC Filing Icon  
6/11/2014Sell157,500$71.83$11,313,225.00View SEC Filing Icon  
11/5/2013Sell150,000$67.20$10,080,000.00View SEC Filing Icon  
5/2/2013Sell245,258$54.41$13,344,487.78View SEC Filing Icon  
See Full Table

Steven H. Collis Buying and Selling Activity at AmerisourceBergen

This chart shows Steven H Collis's buying and selling at AmerisourceBergen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AmerisourceBergen Company Overview

AmerisourceBergen logo
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $186.69
Low: $177.76
High: $193.39

2 Week Range

Now: N/A


806,000 shs

Average Volume

1,432,623 shs

Market Capitalization

$36.39 billion

P/E Ratio


Dividend Yield